Additive manufacturing of bioactive and biodegradable porous iron-akermanite composites for bone regeneration. (August 2022)

• Record Type: Journal Article
• Authors: Putra, N.E.; Borg, K.G.N.; Diaz-Payno, P.J.; Leeflang, M.A.; Klimopoulou, M.; Taheri, P.; Mol, J.M.C.; Fratila-Apachitei, L.E.; Huan, Z.; Chang, J.; Zhou, J.; Zadpoor, A.A.
• Is Part Of: Acta biomaterialia. Volume 148(2022)
• Page Start: 355
• Page End: 373
• Publication Date: 2022-08
• Subjects: Extrusion-based 3D printing -- Biodegradable -- Iron -- Akermanite -- Composite -- Scaffold -- Bone substitution; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2022.06.009
• Languages: English
• ISSNs: 1742-7061

Abstract

Abstract: Advanced additive manufacturing techniques have been recently used to tackle the two fundamental challenges of biodegradable Fe-based bone-substituting materials, namely low rate of biodegradation and insufficient bioactivity. While additively manufactured porous iron has been somewhat successful in addressing the first challenge, the limited bioactivity of these biomaterials hinder their progress towards clinical application. Herein, we used extrusion-based 3D printing for additive manufacturing of iron-matrix composites containing silicate-based bioceramic particles (akermanite), thereby addressing both of the abovementioned challenges. We developed inks that carried iron and 5, 10, 15, or 20 vol% of akermanite powder mixtures for the 3D printing process and optimized the debinding and sintering steps to produce geometrically-ordered iron-akermanite composites with an open porosity of 69–71%. The composite scaffolds preserved the designed geometry and the original α-Fe and akermanite phases. The in vitro biodegradation rates of the composites were improved as much as 2.6 times the biodegradation rate of geometrically identical pure iron. The yield strengths and elastic moduli of the scaffolds remained within the range of the mechanical properties of the cancellous bone, even after 28 days of biodegradation. The composite scaffolds (10–20 vol% akermanite) demonstrated improved MC3T3-E1 cell adhesion and higher levels of cell proliferation. The cellular secretion of collagen type-1 and the alkaline phosphatase activity on the composite scaffolds (10–20 vol% akermanite) were, respectively higher than and comparable to Ti6Al4V in osteogenic medium. Taken together, these results clearly show the potential of 3D printed porous iron-akermanite composites for further development as promising bone substitutes. Statement of significance: Porous iron matrix composites containing akermanite particles were produced by means of multi-material additive manufacturing to address the two fundamental challenges associated with biodegradable iron-based biomaterials, namely very low rate of biodegradation and insufficient bioactivity. Our porous iron-akermanite composites exhibited enhanced biodegradability and superior bioactivity compared to porous monolithic iron scaffolds. The murine bone cells proliferated on the composite scaffolds, and secreted the collagen type-1 matrix that stimulated bony-like mineralization. The results show the exceptional potential of the developed porous iron-based composite scaffolds for application as bone substitutes. Graphical abstract: Image, graphical abstract